Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S. P'Ng
Clinical Outcomes From Venetoclax Based Therapy in Patients With Relapsed/Refractory B-Cell Lymphomas
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Related publications
Cd19-Directed Car T Cell Therapy (Ctl019) for Relapsed/Refractory Diffuse Large B-Cell and Follicular Lymphomas: Four Year Outcomes
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Venetoclax (Ven) in Patients With Relapsed/Refractory Non-Hodgkin Lymphoma (Nhl)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Venetoclax Synergizes With Radiotherapy for Treatment of B-Cell Lymphomas
Cancer Research
Cancer Research
Oncology
Relapsed/Refractory ETP-all Successfully Treated With Novel Combination Therapy Venetoclax With Nelarabine Prior to Allogeneic Stem Cell Transplant
Pathology
Forensic Medicine
Pathology
Interim Report From a Phase 2 Multicenter Study of Tazemetostat, an Ezh2 Inhibitor, in Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Case Series of Nivolumab Treatment in Patients With Relapsed/Refractory Hiv-Related Lymphomas
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Gemcitabine Plus Liposomal Doxorubicin for Relapsed Refractory T-Cell Lymphomas
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
A Phase I Clinical Study of Autologous Dendritic Cell Therapy in Patients With Relapsed or Refractory Multiple Myeloma
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Outcomes in First Relapsed-Refractory Younger Patients With Mantle Cell Lymphoma: Results From the Mantle-First Study
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
